BUTTITTA, Giuseppina
BUTTITTA, Giuseppina
Ingegneria
EFFETTI CITOTOSSICI SINERGICI INDOTTI DALLA COMBINAZIONE SAHA/PARTENOLIDE IN CELLULE DI CARCINOMA MAMMARIO UMANO MDA-MB231
Buttitta, G.
Evaluation of the in vitro and in vivo antineoplastic effects of Parthenolide on MDA-MB231 breast cancer cells
2012-01-01 Lauricella, M; Carlisi, D; D’Anneo, A; Di Bella, S; Emanuele, S; Martinez, R; Buttitta, G; Tesoriere, G
Il partenolide stimola la produzione di ROS e autofagia in cellule di carcinoma mammario MDA-MB231.Il suo analogo solubile DMAPT inibisce la crescita e le metastasi di xenotrapianti di tumori mammari.
2013-01-01 Carlisi D; D'Anneo A; Lauricella M; Martinez R; Emanuele S; Puleio R; Di Bella S; Di Marco P; Buttitta G; Di Fiore R; Guercio A; Vento R; Tesoriere G.
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
2016-01-01 Carlisi, D.; Buttitta, G.; Di Fiore, R.; Scerri, C.; Drago-Ferrante, R.; Vento, R.; Tesoriere, G.
Parthenolide induces EGF receptor phosphorylation and superoxide anion production in MDA-MB231 breast cancer cells.
2013-01-01 Lauricella, M; D'Anneo, A; Carlisi, D; Emanuele, S; Buttitta, G; Martinez, R; Di Fiore, R; Vento, R; Tesoriere G.
Parthenolide induces superoxide anion production by stimulating EGF receptor in MDA-MB-231 breast cancer cells.
2013-01-01 D'ANNEO, A; CARLISI, D; EMANUELE, S; BUTTITTA, G; DI FIORE, R; VENTO, R; TESORIERE, G; LAURICELLA, M
Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2
2017-01-01 Carlisi, D.; De Blasio Anna, ; Drago-Ferrante, R.; Di Fiore Riccardo, ; Buttitta, G.; Morreale, M.; Scerri, C.; Vento, R.; Tesoriere, G.
Retinoblastoma: History of His Identification, Characterization and Treatment
2014-01-01 Di Fiore, R.; De Blasio, A.; Drago-Ferrante, R.; Carlisi, D.; Marcatti, M.; Buttitta, G.; Tesoriere, G; Vento, R.
Synergistic cytotoxic interaction of the HDAC inhibitor SAHA with the natural compound parthenolide in MDA-MB231 breast cancer cells.
2013-01-01 Carlisi, D; D'Anneo, A; Lauricella, M; Emanuele, S; Martinez, R; Buttitta, G; Vento, R; Tesoriere G
Synergistic effect of the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide in triple negative breast cancer cells.
2014-01-01 D’Anneo, A; Lauricella, M; Carlisi, D; Emanuele, S; Buttitta, G; Vento, R; Tesoriere, G
The cytotoxic effect exerted by parthenolide and DMAPT on breast cancer stem-like cells
2015-01-01 Buttitta, G.; Carlisi, D.; DI FIORE, R.; Scerri, C.; Vento, R.; Tesoriere, G.
The HDAC inhibitor SAHA synergistically stimulates the cytotoxic effect induced by Parthenolide in MDA-MB231 cells
2014-01-01 Carlisi, D; D'Anneo, A; Lauricella, M; Buttitta, G; Emanuele, S; Martinez, R; Vento, R; Tesoriere, G
The oxygen radicals involved in the toxicity induced by parthenolide in MDA-MB-231 cells
2014-01-01 Carlisi, D; D'Anneo, A; Martinez, R; Emanuele, S; Buttitta, G; Di Fiore, R; Vento, R; Tesoriere, G; Lauricella, M
The synergistic effect exerted by the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide on triple negative breast canc er cells
2014-01-01 Carlisi, D; D’Anneo, A; Lauricella, M; Buttitta, G; Emanuele, S; Martinez, R; Tesoriere, G
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells
2015-01-01 Carlisi, D.; Lauricella, M.; D'Anneo, A.; Buttitta, G.; Emanuele, S.; di Fiore, R.; Martinez, R.; Rolfo, C.; Vento, R.; Tesoriere, G.